Marc Hedrick
Net worth: 163 420 $ as of 2026-05-30
Net worth: 163 420 $ as of 2026-05-30
Marc H.
Hedrick was the founder of StemSource, Inc., founded in 2000, where the titles held included President, Chief Executive Officer & Director from 2001 to 2003.
Dr. Hedrick currently holds the positions of President, Chief Executive Officer & Director at Plus Therapeutics, Inc. since 2019.
Former jobs include President, Chief Executive Officer & Director at Cytori Therapeutics, Inc. (JP); Chief Scientific Officer & Medical Director at MacroPore Biosurgery, Inc. from 2002 to 2004; Co-Director at UCLA Anderson School of Management; Director at Cytori Ltd.; and Associate Professor at the University of California, Los Angeles.
Education includes a doctorate from The University of Texas Southwestern Medical Center conferred in 1988 and an MBA from UCLA Anderson School of Management conferred in 2005.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-13 | 28,044 ( 0.41% ) | 163 216 $ | 2026-05-30 | |
| 2018-07-24 | 35 ( -.--% ) | 204 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| PLUS THERAPEUTICS, INC. | Chief Executive Officer | 2014-04-01 |
| Companies | Position | End |
|---|---|---|
MacroPore Biosurgery, Inc. /Old/
MacroPore Biosurgery, Inc. /Old/ Medical SpecialtiesHealth Technology Manufactures biocompatible surgical implants for the reconstruction and regeneration of bones | Chief Tech/Sci/R&D Officer | 2003-12-31 |
StemSource, Inc.
StemSource, Inc. Miscellaneous Commercial ServicesCommercial Services Develops treatements to cancer | Founder | 2002-12-31 |
UCLA Anderson School of Management
UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Cytori Therapeutics, Inc. (JP)
Cytori Therapeutics, Inc. (JP) BiotechnologyHealth Technology Provides cell therapy treatments and services | Chief Executive Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 8 |
|---|---|
MacroPore Biosurgery, Inc. /Old/
MacroPore Biosurgery, Inc. /Old/ Medical SpecialtiesHealth Technology Manufactures biocompatible surgical implants for the reconstruction and regeneration of bones | Health Technology |
StemSource, Inc.
StemSource, Inc. Miscellaneous Commercial ServicesCommercial Services Develops treatements to cancer | Commercial Services |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Plus Therapeutics, Inc.
Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
The University of Texas Southwestern Medical Center
The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cytori Ltd.
Cytori Ltd. Pharmaceuticals: OtherHealth Technology Develops biological products | Health Technology |
Cytori Therapeutics, Inc. (JP)
Cytori Therapeutics, Inc. (JP) BiotechnologyHealth Technology Provides cell therapy treatments and services | Health Technology |
Select your edition
All financial news and data tailored to specific country editions